Health Sciences In The Media Parkinson's Drug Eyed as Treatment for Severe Macular Degeneration Sept. 16, 2020 Continuing coverage: Investigators have determined that treating patients with an advanced form of age-related macular degeneration with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision. It reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the burden of treating the disease, financially and otherwise. Dr. Robert W. Snyder, head of the Department of Ophthalmology at the University of the Arizona, is the study's lead investigator. U.S. News & World Report Genome Study Finds 11 Early Sources for COVID-19 in Arizona Sept. 16, 2020 Continuing coverage: Molecular clock analysis showed no widespread community distribution of the highly contagious coronavirus disease in Arizona until mid-February. The Associated Press State Pushes Flu Vaccinations to Avert Flu-and-COVID-19 'Perfect Storm' Sept. 15, 2020 Just over two in five Arizona adults got a flu shot last year, a number state officials are desperate to improve on before the onset of both influenza and the ongoing COVID-19 pandemic this fall. "It's difficult to tell what the response will be each year" to the call for people to get vaccinated, said Dr. Daniel Derksen, director of the University of Arizona Center for Rural Health. "You want to protect those vulnerable populations." Cronkite News As Threat of Valley Fever Grows Beyond the Southwest, Push Is on for Vaccine Sept. 15, 2020 Continuing coverage: Efforts are underway to bring to market a vaccine for a fungal infection that occurs in the deserts of the Southwest. With recent studies showing promise, there is a renewed push. Dr. John Galgiani, director of the University of Arizona's Valley Fever Center for Excellence, is heading up vaccine research there and believes the vaccine shown to prevent valley fever in mice should be available for dogs, which also get infected in large numbers, as soon as next year. A veterinary vaccine company, Anivive, is developing it. "It's very promising," said Galgiani. PBS NewsHour UArizona Develops App to Assist Stress, Anxiety From Social Isolation Sept. 15, 2020 University of Arizona researchers have developed an app to assist in reducing stress and anxiety related to social isolation during the COVID-19 pandemic. KVOA-TV The Coronavirus Vaccine Race – and Its Hidden Hurdles Sept. 15, 2020 Labs and factories around the globe are racing to test and produce more than a billion doses of coronavirus vaccine. To shrink a 10-year marathon into a 10-month sprint, they are merging institutional knowledge with novel bioscience methods. "This first round of vaccines is certainly using more of what we would call experimental platforms – things that don't have a lot of track record yet," said Deepta Bhattacharya, a cell biologist and immunologist at the University of Arizona. "Now, that's not to say that it won't work. And to be honest, all of the early data that I'm seeing so far, it looks really quite promising." KJZZ-Radio Chemotherapy Stewardship Offers Opportunities to Reduce Costs to Health Systems, Patients Sept. 15, 2020 As cancer care costs continue to increase in the United States, a focus on chemotherapy stewardship may result in cost savings for health systems and patients. During a session of the Hematology/Oncology Pharmacy Association Practice Management 2020 Virtual Learning Event, presenter Ali McBride, clinical coordinator of hematology/oncology for the University of Arizona Cancer Center, said a 2011 projection by the National Cancer Institute estimated there would be 18.1 million cancer survivors in the United States in 2020, which represents a 30% increase in the number of cancer survivors since 2010. Pharmacy Times Promising Results From Initial Use of the COVID-19 Antigens Tests Central to Pac-12 Football's Return Sept. 15, 2020 By the end of the month, tens of thousands of rapid-response antigen tests will be delivered to athletic departments across the Pac-12. One school – the University of Arizona – began using the tests months ago. The university has run 25,000 Quidel tests on students, athletes, staff members and ICU patients since the spring. David Harris, who oversees the program, said the results have been impressive. "It only seems to get better the more you do it," he said. Arizona Daily Star 'Bear Down, Mask up' and Shelter in Place: UA Announces Recommendations to Curb COVID-19 Surge Sept. 14, 2020 University of Arizona President Robert C. Robbins said the university expected to see an increase in COVID-19 cases, but it has become too much, necessitating a shelter-in-place recommendation similar to what the state faced in the spring. The Arizona Republic UArizona Researchers Find Minimal Difference in Hand-Drying Methods Sept. 14, 2020 A University of Arizona Health Sciences research team reviewed nearly 300 published studies on the hygienic benefits of hand-drying methods, comparing paper towels to electric hand dryers. "Neither one's better. The most important thing is that you just dry your hands," said Kelly Reynolds, director of the Environment, Exposure Science and Risk Assessment Center at the Mel and Enid Zuckerman College of Public Health. KTAR-FM Phoenix Pagination « First First page ‹ Previous Previous page … 275 276 277 278 279 280 281 282 283 … Next › Next page Last » Last page
Parkinson's Drug Eyed as Treatment for Severe Macular Degeneration Sept. 16, 2020 Continuing coverage: Investigators have determined that treating patients with an advanced form of age-related macular degeneration with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision. It reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the burden of treating the disease, financially and otherwise. Dr. Robert W. Snyder, head of the Department of Ophthalmology at the University of the Arizona, is the study's lead investigator. U.S. News & World Report
Genome Study Finds 11 Early Sources for COVID-19 in Arizona Sept. 16, 2020 Continuing coverage: Molecular clock analysis showed no widespread community distribution of the highly contagious coronavirus disease in Arizona until mid-February. The Associated Press
State Pushes Flu Vaccinations to Avert Flu-and-COVID-19 'Perfect Storm' Sept. 15, 2020 Just over two in five Arizona adults got a flu shot last year, a number state officials are desperate to improve on before the onset of both influenza and the ongoing COVID-19 pandemic this fall. "It's difficult to tell what the response will be each year" to the call for people to get vaccinated, said Dr. Daniel Derksen, director of the University of Arizona Center for Rural Health. "You want to protect those vulnerable populations." Cronkite News
As Threat of Valley Fever Grows Beyond the Southwest, Push Is on for Vaccine Sept. 15, 2020 Continuing coverage: Efforts are underway to bring to market a vaccine for a fungal infection that occurs in the deserts of the Southwest. With recent studies showing promise, there is a renewed push. Dr. John Galgiani, director of the University of Arizona's Valley Fever Center for Excellence, is heading up vaccine research there and believes the vaccine shown to prevent valley fever in mice should be available for dogs, which also get infected in large numbers, as soon as next year. A veterinary vaccine company, Anivive, is developing it. "It's very promising," said Galgiani. PBS NewsHour
UArizona Develops App to Assist Stress, Anxiety From Social Isolation Sept. 15, 2020 University of Arizona researchers have developed an app to assist in reducing stress and anxiety related to social isolation during the COVID-19 pandemic. KVOA-TV
The Coronavirus Vaccine Race – and Its Hidden Hurdles Sept. 15, 2020 Labs and factories around the globe are racing to test and produce more than a billion doses of coronavirus vaccine. To shrink a 10-year marathon into a 10-month sprint, they are merging institutional knowledge with novel bioscience methods. "This first round of vaccines is certainly using more of what we would call experimental platforms – things that don't have a lot of track record yet," said Deepta Bhattacharya, a cell biologist and immunologist at the University of Arizona. "Now, that's not to say that it won't work. And to be honest, all of the early data that I'm seeing so far, it looks really quite promising." KJZZ-Radio
Chemotherapy Stewardship Offers Opportunities to Reduce Costs to Health Systems, Patients Sept. 15, 2020 As cancer care costs continue to increase in the United States, a focus on chemotherapy stewardship may result in cost savings for health systems and patients. During a session of the Hematology/Oncology Pharmacy Association Practice Management 2020 Virtual Learning Event, presenter Ali McBride, clinical coordinator of hematology/oncology for the University of Arizona Cancer Center, said a 2011 projection by the National Cancer Institute estimated there would be 18.1 million cancer survivors in the United States in 2020, which represents a 30% increase in the number of cancer survivors since 2010. Pharmacy Times
Promising Results From Initial Use of the COVID-19 Antigens Tests Central to Pac-12 Football's Return Sept. 15, 2020 By the end of the month, tens of thousands of rapid-response antigen tests will be delivered to athletic departments across the Pac-12. One school – the University of Arizona – began using the tests months ago. The university has run 25,000 Quidel tests on students, athletes, staff members and ICU patients since the spring. David Harris, who oversees the program, said the results have been impressive. "It only seems to get better the more you do it," he said. Arizona Daily Star
'Bear Down, Mask up' and Shelter in Place: UA Announces Recommendations to Curb COVID-19 Surge Sept. 14, 2020 University of Arizona President Robert C. Robbins said the university expected to see an increase in COVID-19 cases, but it has become too much, necessitating a shelter-in-place recommendation similar to what the state faced in the spring. The Arizona Republic
UArizona Researchers Find Minimal Difference in Hand-Drying Methods Sept. 14, 2020 A University of Arizona Health Sciences research team reviewed nearly 300 published studies on the hygienic benefits of hand-drying methods, comparing paper towels to electric hand dryers. "Neither one's better. The most important thing is that you just dry your hands," said Kelly Reynolds, director of the Environment, Exposure Science and Risk Assessment Center at the Mel and Enid Zuckerman College of Public Health. KTAR-FM Phoenix